{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:51:19Z","timestamp":1791910279447,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatitis C virus (HCV) remains underdiagnosed in the United States despite recommendations for universal screening. A simple approach based on readily available demographic information may help target screening in settings where screening implementation continues to be incomplete.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 10 NHANES cycles (1999\u20132014 and 2017\u20132023) and defined HCV exposure as a positive HCV antibody or RNA result. Using sex, birth year, race\/ethnicity, birthplace, and income-to-poverty ratio, we trained and compared logistic regression (LR) and machine learning models in training and cycle-based internal validation cohorts (48,434 and 20,762 participants, respectively). Model performance was evaluated based on sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and the area under the receiver operating characteristic curve (AUROC). A web-based calculator was developed to estimate HCV-marker positivity risk and support prioritization of confirmatory HCV testing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      69,196 participants were included, with 967 showing evidence of HCV exposure. Weighted HCV prevalence remained relatively stable across cycles, ranging from 1.22% to 1.93%. The prevalence did not change significantly after the pandemic. Earlier birth year, male sex, non-Hispanic Black race, US-born status, and lower income-to-poverty ratio were independently associated with HCV exposure. XGBoost performed better than LR in the validation cohort (AUROC 0.859 vs. 0.762,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), but PPV remained low (5.1%). In the RNA-positive sensitivity analysis, XGBoost again showed the best validation performance (AUROC 0.867). Predicted risk showed clear risk stratification: observed HCV prevalence increased from 0.05% in the lowest-risk decile to 7.80% in the highest, with the top decile containing 57.2% of participants with HCV exposure and the top three deciles containing 86.2%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Five demographic variables were sufficient to build a supportive HCV-exposure risk stratification model in a nationally representative US sample. Most HCV-exposed individuals were concentrated in the highest predicted-risk groups, suggesting that this approach could help prioritize outreach and confirmatory testing where universal screening uptake remains incomplete. Because no laboratory data are required, it may also be practical in data-limited settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-28311-2","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:45:37Z","timestamp":1783406737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a machine learning model for evidence of prior or current HCV infection: a demographic screening approach for the US population"],"prefix":"10.1186","volume":"26","author":[{"given":"Dorian G","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S. H.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2661-0635","authenticated-orcid":false,"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"4","key":"28311_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/s2468-1253(22)00386-7","volume":"8","author":"F Cui","year":"2023","unstructured":"Cui F, Blach S, Manzengo Mingiedi C, et al. Global reporting of progress towards elimination of hepatitis B and hepatitis C. Lancet Gastroenterol Hepatol. 2023;8(4):332\u201342. https:\/\/doi.org\/10.1016\/s2468-1253(22)00386-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"28311_CR2","unstructured":"World Health Organization, Hepatitis C, World Health O. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c.\u00a0Accessed 2026 April 1."},{"issue":"2","key":"28311_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/hep.0000000000000927","volume":"81","author":"EW Hall","year":"2025","unstructured":"Hall EW, Bradley H, Barker LK, et al. Estimating hepatitis C prevalence in the United States, 2017\u20132020. Hepatology. 2025;81(2):625\u201336. https:\/\/doi.org\/10.1097\/hep.0000000000000927.","journal-title":"Hepatology"},{"issue":"8","key":"28311_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/cid\/ciu077","volume":"58","author":"R Mahajan","year":"2014","unstructured":"Mahajan R, Xing J, Liu SJ, et al. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006\u20132010. Clin Infect Dis. 2014;58(8):1055\u201361. https:\/\/doi.org\/10.1093\/cid\/ciu077.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"28311_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/ajg.2015.203","volume":"110","author":"SC Gordon","year":"2015","unstructured":"Gordon SC, Lamerato LE, Rupp LB, et al. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational Study. Am J Gastroenterol. 2015;110(8):1169\u201377. https:\/\/doi.org\/10.1038\/ajg.2015.203.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"28311_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"JP Messina","year":"2015","unstructured":"Messina JP, Humphreys I, Flaxman A, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77\u201387. https:\/\/doi.org\/10.1002\/hep.27259.","journal-title":"Hepatology"},{"issue":"27","key":"28311_CR7","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1056\/NEJMoa1512610","volume":"373","author":"JJ Feld","year":"2015","unstructured":"Feld JJ, Jacobson IM, H\u00e9zode C, et al. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. N Engl J Med. 2015;373(27):2599\u2013607. https:\/\/doi.org\/10.1056\/NEJMoa1512610.","journal-title":"N Engl J Med"},{"issue":"5","key":"28311_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/s2468-1253(21)00472-6","volume":"7","author":"HCV Polaris Observatory","year":"2022","unstructured":"Polaris Observatory HCV, Collaborators. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol. 2022;7(5):396\u2013415. https:\/\/doi.org\/10.1016\/s2468-1253(21)00472-6.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"28311_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2018.02.015","volume":"53","author":"A Andriulli","year":"2018","unstructured":"Andriulli A, Stroffolini T, Mariano A, et al. Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas. Eur J Intern Med. 2018;53:79\u201384. https:\/\/doi.org\/10.1016\/j.ejim.2018.02.015.","journal-title":"Eur J Intern Med"},{"issue":"12","key":"28311_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S2468-1253(17)30249-2","volume":"2","author":"MW Sonderup","year":"2017","unstructured":"Sonderup MW, Afihene M, Ally R, et al. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. Lancet Gastroenterol Hepatol. 2017;2(12):910\u20139. https:\/\/doi.org\/10.1016\/S2468-1253(17)30249-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"28311_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/ciad411","volume":"77","author":"KC Lewis","year":"2023","unstructured":"Lewis KC, Barker LK, Jiles RB, Gupta N. Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020. Clin Infect Dis. 2023;77(10):1413\u20135. https:\/\/doi.org\/10.1093\/cid\/ciad411.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"28311_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/infdis\/jiz479","volume":"221","author":"B Zou","year":"2020","unstructured":"Zou B, Yeo YH, Le MH, et al. Prevalence of Viremic Hepatitis C Virus Infection by Age, Race\/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999\u20132016. J Infect Dis. 2020;221(3):408\u201318. https:\/\/doi.org\/10.1093\/infdis\/jiz479.","journal-title":"J Infect Dis"},{"issue":"10","key":"28311_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jama.2020.1123","volume":"323","author":"DK Owens","year":"2020","unstructured":"US Preventive Services Task Force, Owens DK, Davidson KW, et al. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(10):970\u20135. https:\/\/doi.org\/10.1001\/jama.2020.1123.","journal-title":"JAMA"},{"issue":"2","key":"28311_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","volume":"69","author":"S Schillie","year":"2020","unstructured":"Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020. MMWR Recomm Rep. 2020;69(2):1\u201317. https:\/\/doi.org\/10.15585\/mmwr.rr6902a1. Published 2020 Apr 10.","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"28311_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S2468-1253(20)30303-4","volume":"6","author":"F Jin","year":"2021","unstructured":"Jin F, Dore GJ, Matthews G, et al. Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(1):39\u201356. https:\/\/doi.org\/10.1016\/S2468-1253(20)30303-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"28311_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/AOG.0000000000004822","volume":"140","author":"HW Kaufman","year":"2022","unstructured":"Kaufman HW, Osinubi A, Meyer WA 3rd, et al. Hepatitis C Virus Testing During Pregnancy After Universal Screening Recommendations. Obstet Gynecol. 2022;140(1):99\u2013101. https:\/\/doi.org\/10.1097\/AOG.0000000000004822.","journal-title":"Obstet Gynecol"},{"issue":"13","key":"28311_CR17","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.3201\/eid3013.230859","volume":"30","author":"M McNamara","year":"2024","unstructured":"McNamara M, Furukawa N, Cartwright EJ, Advancing Hepatitis C. Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States. Emerg Infect Dis. 2024;30(13):S80\u20137. https:\/\/doi.org\/10.3201\/eid3013.230859.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"28311_CR18","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.arth.2023.08.045","volume":"38","author":"B Khosravi","year":"2023","unstructured":"Khosravi B, Weston AD, Nugen F, et al. Demystifying Statistics and Machine Learning in Analysis of Structured Tabular Data. J Arthroplasty. 2023;38(10):1943\u20137. https:\/\/doi.org\/10.1016\/j.arth.2023.08.045.","journal-title":"J Arthroplasty"},{"issue":"1","key":"28311_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jamia\/ocw042","volume":"24","author":"BA Goldstein","year":"2017","unstructured":"Goldstein BA, Navar AM, Pencina MJ, Ioannidis JP. Opportunities and challenges in developing risk prediction models with electronic health records data: a systematic review. J Am Med Inf Assoc. 2017;24(1):198\u2013208. https:\/\/doi.org\/10.1093\/jamia\/ocw042.","journal-title":"J Am Med Inf Assoc"},{"issue":"6","key":"28311_CR20","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.1109\/TNNLS.2022.3229161","volume":"35","author":"V Borisov","year":"2024","unstructured":"Borisov V, Leemann T, Sebler K, Haug J, Pawelczyk M, Kasneci G. Deep Neural Networks and Tabular Data: A Survey. IEEE Trans Neural Netw Learn Syst. 2024;35(6):7499\u2013519. https:\/\/doi.org\/10.1109\/TNNLS.2022.3229161.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"issue":"8","key":"28311_CR21","doi-asserted-by":"publisher","first-page":"ofaf496","DOI":"10.1093\/ofid\/ofaf496","volume":"12","author":"SC Jang","year":"2025","unstructured":"Jang SC, Lo-Ciganic WH, Hernandez-Con P, et al. Development and Validation of a Machine Learning-Based Screening Algorithm to Predict High-Risk Hepatitis C Infection. Open Forum Infect Dis. 2025;12(8):ofaf496. https:\/\/doi.org\/10.1093\/ofid\/ofaf496. Published 2025 Aug 15.","journal-title":"Open Forum Infect Dis"},{"key":"28311_CR22","unstructured":"National Center for Health Statistics, Centers for Disease Control and Prevention. NHANES Research Ethics Review Board Approval. National Health and Nutrition Examination Survey. 2024. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/default.aspx.\u00a0Accessed 2026 April 1."},{"issue":"9","key":"28311_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"7","key":"28311_CR24","doi-asserted-by":"publisher","first-page":"e70674","DOI":"10.1002\/brb3.70674","volume":"15","author":"L Lin","year":"2025","unstructured":"Lin L, Zhang L, Zhang J, Ding D. A Novel Depression Risk Prediction Model Using NHANES Data With Mendelian Randomization Validation. Brain Behav. 2025;15(7):e70674. https:\/\/doi.org\/10.1002\/brb3.70674.","journal-title":"Brain Behav"},{"issue":"2","key":"28311_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.32142","volume":"75","author":"NS Ramrakhiani","year":"2022","unstructured":"Ramrakhiani NS, Chen VL, Le M, et al. Optimizing hepatitis B virus screening in the United States using a simple demographics-based model. Hepatology. 2022;75(2):430\u20137. https:\/\/doi.org\/10.1002\/hep.32142.","journal-title":"Hepatology"},{"issue":"8","key":"28311_CR26","doi-asserted-by":"publisher","first-page":"e186371","DOI":"10.1001\/jamanetworkopen.2018.6371","volume":"1","author":"ES Rosenberg","year":"2018","unstructured":"Rosenberg ES, Rosenthal EM, Hall EW, et al. Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1(8):e186371. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6371. Published 2018 Dec 7.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"28311_CR27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.30297","volume":"69","author":"MG Hofmeister","year":"2019","unstructured":"Hofmeister MG, Rosenthal EM, Barker LK, et al. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013\u20132016. Hepatology. 2019;69(3):1020\u201331. https:\/\/doi.org\/10.1002\/hep.30297.","journal-title":"Hepatology"},{"issue":"4","key":"28311_CR28","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1109\/TNNLS.2024.3392355","volume":"36","author":"V Dentamaro","year":"2025","unstructured":"Dentamaro V, Giglio P, Impedovo D, Pirlo G, Ciano MD. An Interpretable Adaptive Multiscale Attention Deep Neural Network for Tabular Data. IEEE Trans Neural Netw Learn Syst. 2025;36(4):6995\u20137009. https:\/\/doi.org\/10.1109\/TNNLS.2024.3392355.","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"key":"28311_CR29","doi-asserted-by":"publisher","unstructured":"Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. Topic Group \u2018Evaluating diagnostic tests and prediction models\u2019 of the STRATOS initiative. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230. https:\/\/doi.org\/10.1186\/s12916-019-1466-7.\u00a0Published 2019 Dec 16.","DOI":"10.1186\/s12916-019-1466-7"},{"key":"28311_CR30","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. https:\/\/doi.org\/10.1136\/bmj-2023-078378. Published 2024 Apr 16.","journal-title":"BMJ"},{"issue":"6","key":"28311_CR31","doi-asserted-by":"publisher","first-page":"e005242","DOI":"10.1136\/bmjdrc-2025-005242","volume":"13","author":"W Mou","year":"2025","unstructured":"Mou W, Shan W, Yu S, et al. Interpretable machine learning model for predicting recurrence in patients with diabetic foot ulcers. BMJ Open Diabetes Res Care. 2025;13(6):e005242. https:\/\/doi.org\/10.1136\/bmjdrc-2025-005242. Published 2025 Nov 12.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"28311_CR32","doi-asserted-by":"publisher","first-page":"e955","DOI":"10.1093\/cid\/ciac175","volume":"75","author":"M Hoenigl","year":"2022","unstructured":"Hoenigl M, Abramovitz D, Flores Ortega RE, Martin NK, Reau N. Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States. Clin Infect Dis. 2022;75(1):e955\u201361. https:\/\/doi.org\/10.1093\/cid\/ciac175.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"28311_CR33","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","volume":"108","author":"JE Zibbell","year":"2018","unstructured":"Zibbell JE, Asher AK, Patel RC, et al. Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175\u201381. https:\/\/doi.org\/10.2105\/AJPH.2017.304132.","journal-title":"Am J Public Health"},{"issue":"6","key":"28311_CR34","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","volume":"57","author":"M Schaefer","year":"2012","unstructured":"Schaefer M, Capuron L, Friebe A, et al. Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement. J Hepatol. 2012;57(6):1379\u201390. https:\/\/doi.org\/10.1016\/j.jhep.2012.07.037.","journal-title":"J Hepatol"},{"issue":"1","key":"28311_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2049936115585942","volume":"3","author":"P Cacoub","year":"2016","unstructured":"Cacoub P, Comarmond C, Domont F, Savey L, Desbois AC, Saadoun D. Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis. 2016;3(1):3\u201314. https:\/\/doi.org\/10.1177\/2049936115585942.","journal-title":"Ther Adv Infect Dis"},{"issue":"6","key":"28311_CR36","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jhep.2011.06.004","volume":"55","author":"MF Bassendine","year":"2011","unstructured":"Bassendine MF, Sheridan DA, Felmlee DJ, Bridge SH, Toms GL, Neely RD. HCV and the hepatic lipid pathway as a potential treatment target. J Hepatol. 2011;55(6):1428\u201340. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.004.","journal-title":"J Hepatol"},{"issue":"11","key":"28311_CR37","doi-asserted-by":"publisher","first-page":"705","DOI":"10.17235\/reed.2025.11405\/2025","volume":"117","author":"J Mora Vallellano","year":"2025","unstructured":"Mora Vallellano J, C\u00e1rdenas Lafuente F, Fern\u00e1ndez Esp\u00ednola S, et al. Closing the care gap \u2013 Systematic identification of overlooked patients with hepatitis C. Rev Esp Enferm Dig. 2025;117(11):705\u20136. https:\/\/doi.org\/10.17235\/reed.2025.11405\/2025.","journal-title":"Rev Esp Enferm Dig"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28311-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:42:15Z","timestamp":1789645335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28311-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28311"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28311-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The protocol of NHANES was approved by the National Center for Health Statistics Research Ethics Review Board, and all participants in the database provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2620"}}